PR Newswire
08 Sep 2022, 18:24 GMT+10
MELBOURNE, Australia and SAN DIEGO, Sept. 8, 2022 /PRNewswire/ -- Global MedTech start-up Nutromics has raised an additional US $14 million for its wearable diagnostic platform. This transformative funding is key to Nutromics' continued expansion across Australia and the United States. Strategic investors included Dexcom Ventures, VU Venture Partners, and Artesian Investments.
This funding demonstrates a resounding level of investor confidence in the potential of Nutromics' technology, which will tackle some of healthcare's most challenging conditions through the power of continuous diagnostic monitoring. Nutromics plans to raise significantly more funding in 2023 following in-vivo clinical studies.
"We are aiming to cause a paradigm shift in diagnostic healthcare by essentially developing a lab-on-a-patch. A lack of timely and continuous diagnostic insights can strongly impact outcomes when dealing with critical disease states. With this strategic industry and VC investment in us, we see more confidence in our technology and hope to accelerate our growth, as the need for our platform in the lab diagnostic space is urgent", said Nutromics' co-founder and CEO Peter Vranes.
Nutromics is developing a wearable diagnostic platform that uses DNA technology to enable tracking for multiple targets in the human body using a single patch. This is the first technology of its kind that is both a platform and proven to work on-body. The DNA sensor technology will provide clinicians and patients with continuous and real-time diagnostic information ranging from hard-to-dose drugs, like vancomycin, to biological markers for conditions such as kidney disease.
Nutromics was founded in 2017 and including this recent acceleration round has raised over US$20 million to date for its ground-breaking wearable diagnostic platform. This latest round of funding will support an expansion of clinical studies, expansion of R&D team and investment across both Australian and United States hubs.
The company's exponential growth over the last year, along with this latest round of funding brings Nutromics one step closer to realizing their vision of a world with zero preventable deaths.
About Nutromics
Founded in 2017 by Peter Vranes (CEO) and Hitesh Mehta (COO), Nutromics is on a mission to revolutionize healthcare through continuous diagnostic monitoring, with a vision for a world with zero preventable deaths through personalized and timely diagnostic insights.
Nutromics is developing a wearable diagnostic platform combining microneedles that provide pain-free access to interstitial fluid, just under the skin, and DNA sensor technology.
Nutromics will complete world-first in-human clinical studies of its first DNA sensors in 2022, as well as its integrated alpha prototype device.
SOURCE Nutromics
Get a daily dose of Malaysia Sun news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Malaysia Sun.
More InformationLEMBATA, Indonesia: Indonesia's Mount Lewotobi Laki Laki erupted dramatically on June 18, generating substantial ash and smoke plumes....
NEW DELHI, India: Indian investigators are examining the black boxes from a Boeing 787 Dreamliner to determine the cause of a catastrophic...
NEW DELHI, India: The flight data recorder from the crashed Air India plane was found on June 13. This vital discovery may help investigators...
WUSHI, Taiwan: Inspired by how Ukraine has used sea drones effectively against Russia in the Black Sea, Taiwan is learning how to use...
NEW DELHI, India: Amid mounting U.S.-China trade tensions, Apple has sharply increased iPhone shipments from India to the United States,...
In Nepal's latest attempt to silence online speech, police are trying to arrest a well-known journalist who published on his YouTube...
HAYWARD, California: In a significant step toward its commercial debut, Amazon-owned Zoox has unveiled its first factory dedicated...
SAO PAULO, Brazil: Brazil is taking confident steps to restore its dominance in global poultry exports after declaring its commercial...
NEW YORK, New YorK - U.S. stocks closed mixed on Friday, with gains and losses modest, as investors and traders weighed up the escalation...
WASHINGTON, D.C.: Retail sales dropped sharply in May as consumer spending slowed after a strong start to the year, primarily due to...
WASHINGTON, D.C.: Mitsubishi Motors is the latest automaker to raise prices in the United States, joining a growing list of car companies...
INDIANAPOLIS, Indiana: Eli Lilly is making a bold play in cardiovascular gene therapy, announcing plans to acquire its partner Verve...